Autobio Diagnostics Co., Ltd. Provides Earnings Guidance for the Year 2017
January 29, 2018
Share
Autobio Diagnostics Co., Ltd. Provided earnings guidance for the year 2017. The company predicts that the net profit belonging to shareholders in 2017 will increase by between RMB 69,951,600 and RMB 122,415,300, with an increase of between 20% and 35% compared with the same period of the year before. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will increase by between RMB 50,914,700 and RMB 105,378,400, with an increase of between 15% and 31% compared with the same period of the year before.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
